Last reviewed · How we verify
NCT05237154
Intermittent Fasting and Exercise: Effects on Gut Microbiota, Body Composition and Inflammation.
NA trial testing Intervention with intermittent fasting. in Composition and Function of the Gut Microbiota Post Intervention in 60 participants. Completed in 30 January 2019.
15 December 2018
Quick facts
| Lead sponsor | University of Sao Paulo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 July 2018 |
| Primary completion | 15 December 2018 |
| Estimated completion | 30 January 2019 |
| Sites | 2 locations across Brazil |
Drugs / interventions tested
- Intervention with intermittent fasting.
- Intervention with high-intensity interval training.
Conditions studied
- Composition and Function of the Gut Microbiota Post Intervention — all drugs for Composition and Function of the Gut Microbiota Post Intervention →
- Metabolic and Inflammatory Variables Post Intervention — all drugs for Metabolic and Inflammatory Variables Post Intervention →
Sponsor
University of Sao Paulo
Who can join
Adults 18 to 40, female only, with Composition and Function of the Gut Microbiota Post Intervention or Metabolic and Inflammatory Variables Post Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obesity and overweight affect around 2 billion people worldwide. Despite the growing prevalence, the treatment of obesity is still an obscure field and the impacts of this disease on the clinical and public health perspective are urgent. Studies have demonstrated a fundamental role of the gut microbiota in the pathogenesis of obesity and discuss the impacts of diet and physical exercise on the microbiome profile. However, the mechanisms involved in these processes, referring to strategies such as intermittent fasting associated with physical training, are still poorly explored and understood. It is believed that intermittent fasting combined with physical exercise can promote a remodeling of the composition and function of the microbiota and that the present investigation is promising in the prevention and treatment of obesity.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impact of Intermittent Fasting Combined With High-Intensity Interval Training on Body Composition, Metabolic Biomarkers, and Physical Fitness in Women With Obesity.
Batitucci G, Faria Junior EV, Nogueira JE, Brandão CFC, et al · · 2022 · cited 21× · PMID 35694163 · DOI 10.3389/fnut.2022.884305 -
Intermittent fasting and high-intensity interval training do not alter gut microbiota composition in adult women with obesity.
Batitucci G, Almeida OG, De Martinis ECP, Solar I, et al · · 2024 · cited 8× · PMID 38922577 · DOI 10.1152/ajpendo.00310.2023
Verify or expand the search:
- PubMed search for NCT05237154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Sao Paulo trials
Trials by the same sponsor.
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
- NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05237154 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
- Last refreshed: 11 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05237154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing